Abstract:PEGylation is a well-established and clinically proven half-life extension strategy for protein delivery. Protein modification with amine-reactive poly(ethylene glycol) (PEG) generates heterogeneous and complex bioconjugate mixtures, often composed of several PEG positional isomers with varied therapeutic efficacy. Laborious and costly experiments for reaction optimization and purification are needed to generate a therapeutically useful PEG conjugate. Kinetic models which accurately predict the outcome of so-called "random" PEGylation reactions provide an opportunity to bypass extensive wet lab experimentation and streamline the bioconjugation process. In this study, we propose a protein tertiary structure-dependent reactivity model that describes the rate of protein-amine PEGylation and introduces "PEG chain coverage" as a tangible metric to assess the shielding effect of PEG chains. This structure-dependent reactivity model was implemented into three models (linear, structure-based, and machine-learned) to gain insight into how protein-specific molecular descriptors (exposed surface areas, pKa, and surface charge) impacted amine reactivity at each site. Linear and machine-learned models demonstrated over 75% prediction accuracy with butylcholinesterase. Model validation with Somavert, PEGASYS, and phenylalanine ammonia lyase showed good correlation between predicted and experimentally determined degrees of modification. Our structure-dependent reactivity model was also able to simulate PEGylation progress curves and estimate "PEGmer" distribution with accurate predictions across different proteins, PEG linker chemistry, and PEG molecular weights. Moreover, in-depth analysis of these simulated reaction curves highlighted possible PEG conformational transitions (from dumbbell to brush) on the surface of lysozyme, as a function of PEG molecular weight.

Hydrodynamic and thermodynamic analysis of PEGylated human serum albumin

The molecular basis for hydrodynamic properties of PEGylated human serum albumin

Predicting Colloidal Stability of High-Concentration Monoclonal Antibody Formulations in Common Pharmaceutical Buffers Using Improved Polyethylene Glycol Induced Protein Precipitation Assay.

Moving Protein PEGylation from an Art to a Data Science

In vivo metabolism and safety evaluation of PEGylated proteins drugs

Effect of Grafted PEG Chain Conformation on Albumin and Lysozyme Adsorption: A Combined Study Using QCM-D and DPI

Investigation of the interaction between poly(ethylene glycol) and protein molecules using low field nuclear magnetic resonance.

How PEGylation Enhances the Stability and Potency of Insulin: a Molecular Dynamics Simulation.

Biophysical Characterization of Interactions between Serum Albumin and Block Copolymer Micelles

Mechanistic Insights Into The Stabilization Of Srcsh3 By Pegylation

Synthesis and Systematic Study on the Effect of Different PEG Units on Stability of PEGylated, Integrin-αvβ6-Specific A20FMDV2 Analogues in Rat Serum and Human Plasma

Temperature dependence of serum protein adsorption in PEGylated PNIPAm microgels

Affinity-Directed Dynamics of Host-Guest Motifs for Pharmacokinetic Modulation Via Supramolecular PEGylation.

Pegylation, a Successful Strategy to Address the Storage and Instability Problems of Blood Products: Review 2011-2021

The Importance of Poly(ethylene glycol) Alternatives for Overcoming PEG Immunogenicity in Drug Delivery and Bioconjugation

Enhanced Colloidal Stability and Protein Resistance of Layered Double Hydroxide Nanoparticles with Phosphonic Acid-Terminated PEG Coating for Drug Delivery.

Insight into the molecular mechanism behind PEG-mediated stabilization of biofluid lipases

Polyethylene Glycol Immunogenicity: Theoretical, Clinical, and Practical Aspects of Anti-Polyethylene Glycol Antibodies

The Chromatographic Behaviour of PEGylated Protein on Cation-Exchangers

Subvisible Particles Derived by Dropping Stress Enhance Anti-PEG Antibody Production and Clearance of PEGylated Proteins in Mice